GlassScriptPhysician profile
Aditya Sharma
NPI 1780845271
$87,722.70
in general payments reported to CMS, 2019-2025
42 companies · $20K in 2025
The $20K reported for 2025 was more than what 93% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,785 · 2020: $899 · 2021: $8,170 · 2022: $15K · 2023: $26K · 2024: $11K · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $29K · Food and Beverage: $11K · Travel and Lodging: $11K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $6,700 · Consulting Fee: $550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $28,689.00 |
| Food and Beverage | $10,685.68 |
| Travel and Lodging | $10,594.98 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $6,700.00 |
| Consulting Fee | $550.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $40,670.47 | 2019-2025 | Camzyos |
| Biotronik INC. | $16,359.00 | 2021-2025 | Nhancer Rx, Recross, Trapit |
| Shockwave Medical, INC | $6,711.26 | 2020-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals LP | $6,345.39 | 2020-2025 | Fasenra, Lokelma, Farxiga |
| Medtronic, INC. | $5,038.57 | 2021-2025 | Venaseal, Symplicity G3, Ffrangio |
| Boston Scientific Corporation | $2,434.04 | 2019-2025 | Avvigo Guidance System, Watchman Access System, Varithena Administration Pack |
| Heartflow, INC. | $1,447.07 | 2025 | |
| Acist Medical Systems, INC. | $1,424.22 | 2021-2025 | |
| Reflow Medical INC | $1,415.18 | 2024-2025 | |
| Baxter Healthcare | $841.51 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Abiomed | $800.16 | 2019-2025 | Impella |
| Philips North America LLC | $548.52 | 2024-2025 | Igt Devices Undivided, Intrasight Integrated, Coronary Other |
| Terumo Medical Corporation | $543.63 | 2019-2025 | R2p Misago, Glidesheath Slender |
| Sanofi-Aventis U.S. LLC | $342.63 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $271.05 | 2019-2025 | Spravato, Xarelto |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gentuity, LLC | $248.10 | 2025 | Gentuity Hf-Oct Imaging System, Vis-Rx Prime |
| Pfizer INC. | $232.44 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $194.48 | 2024-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Cardioform Septal Occluder |
| Bard Peripheral Vascular, INC. | $188.08 | 2020-2023 | Rotarexs 6 F X 135 Cm |
| Abbott Laboratories | $168.40 | 2022-2023 | Thoratec Heartmate 3 Lvas Implant Kit, Dragonfly Opstar |
| Tactile Systems Technology INC | $164.12 | 2025 | Flexitouch Plus, Nimbl |
| Esperion Therapeutics, INC. | $136.53 | 2020-2025 | Nexletol |
| Cardiovascular Systems INC. | $135.01 | 2019-2023 | Diamondback Coronary |
| Daiichi Sankyo INC. | $120.98 | 2023-2025 | Injectafer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $115.61 | 2020-2022 | |
| Inari Medical, INC. | $113.60 | 2021 | |
| Novartis Pharmaceuticals Corporation | $113.42 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $109.55 | 2020-2025 | Jardiance |
| Medtronic Vascular, INC. | $77.93 | 2020 | |
| Bridgebio Pharma, INC. | $64.96 | 2025 | Attruby |
| Bardy Diagnostics, INC. | $55.00 | 2022 | |
| Celonova Biosciences, INC. | $48.44 | 2021 | |
| United Therapeutics Corporation | $45.55 | 2025 | |
| Chiesi USA, INC. | $37.65 | 2019-2021 | |
| Impulse Dynamics (USA) INC. | $37.49 | 2023-2025 | Optimizer, Optimizer |
| Verona Pharma, INC. | $22.03 | 2025 | Ohtuvayre |
| Actelion Pharmaceuticals US, INC. | $20.19 | 2025 | Uptravi |
| Cardiva Medical, INC. | $19.98 | 2023 | Cardiva Vascade 6/7f Vcs |
| Teleflex LLC | $18.00 | 2025 | Guideliner |
| Amgen INC. | $16.12 | 2022 | |
| Viatris Specialty LLC | $15.51 | 2025 | Yupelri |
| Cardinal Health 200 LLC | $10.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aditya Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.